Trials / Completed
CompletedNCT03242824
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
MC167B: Pilot Study Investigating the Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This proposal is for a pilot study comparing volumes of 18F-DOPA-PET avidity with contrast enhancement and T2 FLAIR on MRI. Investigators then plan to compare patterns of failure with target volumes, pre-treatment MRI changes and pre-treatment 18F-DOPA-PET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluorine F 18 Fluorodopa | Contrast used in PET |
| RADIATION | Intensity-Modulated Radiation Therapy | Radiation of different intensities are aimed at the tumor from many angles. This type of radiation therapy reduces the damage to healthy tissue near the tumor |
| PROCEDURE | Positron Emission Tomography | imaging test |
Timeline
- Start date
- 2017-09-29
- Primary completion
- 2020-06-16
- Completion
- 2021-06-16
- First posted
- 2017-08-08
- Last updated
- 2023-03-14
- Results posted
- 2022-07-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03242824. Inclusion in this directory is not an endorsement.